Definitive Healthcare Q2 revenue slightly misses estimates despite customer gains

Definitive Healthcare said second-quarter revenue fell 9% year over year and slightly missed analyst expectations.

The healthcare data analytics firm reported Q2 revenue of $55.20 million, compared with a consensus estimate of $55.48 million from six analysts. Q2 net loss was $7.45 million, and gross profit was $40.54 million.

For the third quarter, Definitive Healthcare sees revenue between $54.0 million and $55.0 million and adjusted net income per diluted share of $0.04 to $0.05.

The company expects full-year 2026 revenue of $220.0 million to $222.0 million.

The current average analyst rating on the shares is hold, with 1 strong buy or buy, 5 hold, and 2 sell or strong sell ratings. The median 12-month price target is $2.75, about 285.4% above the August 7 closing price of $0.71.